SCHEDULE 13D - ORBIMED CAPITAL LLC

Company

BIOCRYST PHARMACEUTICALS INC

Filed

February 26, 2004

Accession Number

0000947871-04-000561

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →